(National Catholic Register. Daniel Payne).
The Supreme Court on Thursday unanimously ruled against a physician-led challenge to the abortion pill, striking down an attempt by advocates to impose stricter regulations on the drug. The Court said in its Thursday ruling that the plaintiffs, represented by the Alliance for Hippocratic Medicine (AHM), lacked standing to challenge U.S. Food and Drug Administration’s (FDA) regulation of the abortion drug mifepristone. AHM, which represents pro-life medical groups, sued the FDA in November 2022 to challenge the agency’s longstanding approval of the drug. The lawsuit further challenged the FDA’s subsequent deregulation of the drug, particularly its permission to prescribe the medicine without an in-person doctor’s visit and to dispense the drug through the mail. The high court heard oral arguments in the case in March of this year.